K

LongRiver Investments logo

LongRiver Investments

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series A

Ouro Medicines logo
Ouro Medicines

Biotechnology • Immune reset therapeutics

UPMC Enterprises logo
TPG Life Sciences Innovations logo
Norwest Venture Partners logo
NEA logo

Ouro Medicines is a biotechnology company developing immune reset therapeutics for chronic immune-mediated diseases, with a focus on B cell biology and T cell engagers.

Series A
$120M
01/10/2025
Article